batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Pfizer confirms Braftovi’s survival benefit 3 February 2025 Take five in T-cell lymphoma 31 January 2025 Early-stage changes at Roche 30 January 2025 Otsuka and Cullinan chase Dizal 30 January 2025 Roche claims an Itovebi breast cancer survival benefit 28 January 2025 Novartis casts a broader Netter for Lutathera 28 January 2025 Lantheus goes Evergreen 28 January 2025 Enhertu goes even lower 28 January 2025 Load More